Literature DB >> 25052297

A prospective study of the relationship between sense of coherence, depression, anxiety, and quality of life of haematopoietic stem cell transplant patients over time.

Brindha Pillay1, Stuart J Lee, Lynda Katona, Sue De Bono, Sue Burney, Sharon Avery.   

Abstract

OBJECTIVES: The primary aim of this study was to examine the impact of patient sense of coherence (SOC) on anxiety and depressive symptoms, and quality of life (QoL) dimensions in the acute phase of haematopoietic stem cell transplantation (HSCT). A secondary aim was to determine if SOC measured pre-transplant was predictive of psychological distress and QoL post-transplantation, after controlling for physical wellbeing.
METHOD: A series of measures was completed by 60 HSCT patients prior to transplantation. Follow-up data were collected at 2-3 weeks and 3 months post-transplantation. Measures administered included the Brief Symptom Inventory-18, Orientation to Life Questionnaire, and Functional Assessment of Cancer Therapy-Bone Marrow Transplantation.
RESULTS: When compared across the three time points, depression levels, and physical and functional wellbeing were worst at 2-3 weeks post-transplantation. SOC was positively associated with physical wellbeing prior to HSCT but not after transplantation. Weaker SOC predicted higher levels of depression, and poorer social, emotional, and functional wellbeing at both follow-up points, after accounting for physical wellbeing.
CONCLUSIONS: Given that SOC was related to depression and QoL dimensions post-transplantation, it may be important for health care professionals to conduct psychosocial assessments to determine patient SOC. This would enable provision of tailored psychological support prior to and following stem cell transplantation.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; haematopoietic stem cell transplant; oncology; psychological distress; quality of life; sense of coherence

Mesh:

Year:  2014        PMID: 25052297     DOI: 10.1002/pon.3633

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  6 in total

1.  Factors associated with post-traumatic stress symptoms experienced in the acute phase following haemopoietic stem cell transplant.

Authors:  B Pillay; S J Lee; L Katona; S De Bono; S Burney; S Avery
Journal:  Bone Marrow Transplant       Date:  2015-11-02       Impact factor: 5.483

2.  Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology.

Authors:  Anna Barata; Brian D Gonzalez; Steven K Sutton; Brent J Small; Paul B Jacobsen; Teresa Field; Hugo Fernandez; Heather Sl Jim
Journal:  J Health Psychol       Date:  2016-04-22

3.  Illness perceptions predict health practices and mental health following hematopoietic stem cell transplantation.

Authors:  Ashley M Nelson; Mark B Juckett; Christopher L Coe; Erin S Costanzo
Journal:  Psychooncology       Date:  2019-04-23       Impact factor: 3.894

4.  A randomized clinical trial on the effectiveness of an intervention to treat psychological distress and improve quality of life after autologous stem cell transplantation.

Authors:  Annemarie M J Braamse; B van Meijel; O J Visser; A D Boenink; P Cuijpers; C E Eeltink; A W Hoogendoorn; M van Marwijk Kooy; P van Oppen; P C Huijgens; A T F Beekman; J Dekker
Journal:  Ann Hematol       Date:  2015-09-30       Impact factor: 3.673

5.  Pre-transplant depression decreased overall survival of patients receiving allogeneic hematopoietic stem cell transplantation: a nationwide cohort study.

Authors:  Sheng-Min Wang; Sung-Soo Park; Si-Hyun Park; Nak-Young Kim; Dong Woo Kang; Hae-Ran Na; Jong Wook Lee; Seunghoon Han; Hyun Kook Lim
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

6.  Health-related quality of life, anxiety and depression in the diagnostic phase of suspected cancer, and the influence of diagnosis.

Authors:  Ellen Moseholm; Susan Rydahl-Hansen; Dorthe Overgaard; Hanne S Wengel; Rikke Frederiksen; Malene Brandt; Bjarne Ø Lindhardt
Journal:  Health Qual Life Outcomes       Date:  2016-05-20       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.